159 related articles for article (PubMed ID: 32614502)
41. Synthesis and tyrosinase inhibitory properties of some novel derivatives of kojic acid.
Saghaie L; Pourfarzam M; Fassihi A; Sartippour B
Res Pharm Sci; 2013 Oct; 8(4):233-42. PubMed ID: 24082892
[TBL] [Abstract][Full Text] [Related]
42. Synthesis, computational studies and enzyme inhibitory kinetics of substituted methyl[2-(4-dimethylamino-benzylidene)-hydrazono)-4-oxo-thiazolidin-5-ylidene]acetates as mushroom tyrosinase inhibitors.
Channar PA; Saeed A; Larik FA; Rafiq M; Ashraf Z; Jabeen F; Fattah TA
Bioorg Med Chem; 2017 Nov; 25(21):5929-5938. PubMed ID: 28988751
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, antioxidant and anti-tyrosinase activity of 1,2,4-triazole hydrazones as antibrowning agents.
Peng Z; Wang G; Zeng QH; Li Y; Wu Y; Liu H; Wang JJ; Zhao Y
Food Chem; 2021 Mar; 341(Pt 2):128265. PubMed ID: 33031957
[TBL] [Abstract][Full Text] [Related]
44. Design, synthesis and biological evaluation of 2-(substituted phenyl)thiazolidine-4-carboxylic acid derivatives as novel tyrosinase inhibitors.
Ha YM; Park YJ; Lee JY; Park D; Choi YJ; Lee EK; Kim JM; Kim JA; Park JY; Lee HJ; Moon HR; Chung HY
Biochimie; 2012 Feb; 94(2):533-40. PubMed ID: 21945595
[TBL] [Abstract][Full Text] [Related]
45. Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies.
Abbas Q; Ashraf Z; Hassan M; Nadeem H; Latif M; Afzal S; Seo SY
Drug Des Devel Ther; 2017; 11():2029-2046. PubMed ID: 28740364
[TBL] [Abstract][Full Text] [Related]
46. Insights into tyrosinase inhibition by compounds isolated from Greyia radlkoferi Szyszyl using biological activity, molecular docking and gene expression analysis.
Lall N; Mogapi E; de Canha MN; Crampton B; Nqephe M; Hussein AA; Kumar V
Bioorg Med Chem; 2016 Nov; 24(22):5953-5959. PubMed ID: 27720556
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.
Mann T; Gerwat W; Batzer J; Eggers K; Scherner C; Wenck H; Stäb F; Hearing VJ; Röhm KH; Kolbe L
J Invest Dermatol; 2018 Jul; 138(7):1601-1608. PubMed ID: 29427586
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of new kojic acid-1,3,4-oxadiazole hybrids as tyrosinase inhibitors and their application in the anti-browning of fresh-cut mushrooms.
Wang G; He M; Huang Y; Peng Z
Food Chem; 2023 May; 409():135275. PubMed ID: 36586247
[TBL] [Abstract][Full Text] [Related]
49. Halogenated aromatic thiosemicarbazones as potent inhibitors of tyrosinase and melanogenesis.
Hałdys K; Goldeman W; Jewgiński M; Wolińska E; Anger-Góra N; Rossowska J; Latajka R
Bioorg Chem; 2020 Jan; 94():103419. PubMed ID: 31761412
[TBL] [Abstract][Full Text] [Related]
50. Structural requirement of phenylthiourea analogs for their inhibitory activity of melanogenesis and tyrosinase.
Thanigaimalai P; Lee KC; Sharma VK; Joo C; Cho WJ; Roh E; Kim Y; Jung SH
Bioorg Med Chem Lett; 2011 Nov; 21(22):6824-8. PubMed ID: 21978680
[TBL] [Abstract][Full Text] [Related]
51. A novel synthesized tyrosinase inhibitor: (E)-2-((2,4-dihydroxyphenyl)diazenyl)phenyl 4-methylbenzenesulfonate as an azo-resveratrol analog.
Bae SJ; Ha YM; Kim JA; Park JY; Ha TK; Park D; Chun P; Park NH; Moon HR; Chung HY
Biosci Biotechnol Biochem; 2013; 77(1):65-72. PubMed ID: 23291747
[TBL] [Abstract][Full Text] [Related]
52. Functionality study of chalcone-hydroxypyridinone hybrids as tyrosinase inhibitors and influence on anti-tyrosinase activity.
Singh LR; Chen YL; Xie YY; Xia W; Gong XW; Hider RC; Zhou T
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1562-1567. PubMed ID: 32746652
[TBL] [Abstract][Full Text] [Related]
53. A Combination of Pharmacophore and Docking-based Virtual Screening to Discover new Tyrosinase Inhibitors.
Vittorio S; Seidel T; Germanò MP; Gitto R; Ielo L; Garon A; Rapisarda A; Pace V; Langer T; De Luca L
Mol Inform; 2020 Mar; 39(3):e1900054. PubMed ID: 31508903
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory effects of macelignan isolated from Myristica fragrans HOUTT. on melanin biosynthesis.
Cho Y; Kim KH; Shim JS; Hwang JK
Biol Pharm Bull; 2008 May; 31(5):986-9. PubMed ID: 18451531
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, biological evaluation, and molecular docking of N-{3-[3-(9-methyl-9H-carbazol-3-yl)-acryloyl]-phenyl}-benzamide/amide derivatives as xanthine oxidase and tyrosinase inhibitors.
Bandgar BP; Adsul LK; Chavan HV; Shringare SN; Korbad BL; Jalde SS; Lonikar SV; Nile SH; Shirfule AL
Bioorg Med Chem; 2012 Sep; 20(18):5649-57. PubMed ID: 22901670
[TBL] [Abstract][Full Text] [Related]
56. Identifying melanogenesis inhibitors from Cinnamomum subavenium with in vitro and in vivo screening systems by targeting the human tyrosinase.
Wang HM; Chen CY; Wen ZH
Exp Dermatol; 2011 Mar; 20(3):242-8. PubMed ID: 21054558
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers.
Larik FA; Saeed A; Channar PA; Muqadar U; Abbas Q; Hassan M; Seo SY; Bolte M
Eur J Med Chem; 2017 Dec; 141():273-281. PubMed ID: 29040952
[TBL] [Abstract][Full Text] [Related]
58. (-)-N-Formylanonaine from Michelia alba as a human tyrosinase inhibitor and antioxidant.
Wang HM; Chen CY; Chen CY; Ho ML; Chou YT; Chang HC; Lee CH; Wang CZ; Chu IM
Bioorg Med Chem; 2010 Jul; 18(14):5241-7. PubMed ID: 20584613
[TBL] [Abstract][Full Text] [Related]
59. Mechanism underlying inhibitory effect of six dicaffeoylquinic acid isomers on melanogenesis and the computational molecular modeling studies.
Ha JH; Park SN
Bioorg Med Chem; 2018 Aug; 26(14):4201-4208. PubMed ID: 30030001
[TBL] [Abstract][Full Text] [Related]
60. Tyrosinase Inhibitors Naturally Present in Plants and Synthetic Modifications of These Natural Products as Anti-Melanogenic Agents: A Review.
Hassan M; Shahzadi S; Kloczkowski A
Molecules; 2023 Jan; 28(1):. PubMed ID: 36615571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
